Literature DB >> 12398532

Neoclerodane and labdane diterpenoids from Plectranthus ornatus.

Patrícia Rijo1, Cristina Gaspar-Marques, M Fátima Simões, Aida Duarte, María Del Carmen Apreda-Rojas, Félix H Cano, Benjamín Rodríguez.   

Abstract

Three new diterpenoids, a neoclerodane and two labdane derivatives, have been isolated from an acetone extract of Plectranthus ornatus. The structures of these compounds (plectrornatins A-C, 1-3, respectively) were established mainly by spectroscopic means, particularly by 1D and 2D NMR studies and, in the case of the neoclerodane 1, by an X-ray diffraction analysis. Compounds 1 and 3 showed moderate antimicrobial activity against five Candida species and selected Gram negative and Gram positive bacteria strains.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12398532     DOI: 10.1021/np020203w

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  4 in total

1.  Screening the dermatological potential of plectranthus species components: antioxidant and inhibitory capacities over elastase, collagenase and tyrosinase.

Authors:  Joana M Andrade; Eva María Domínguez-Martín; Marisa Nicolai; Célia Faustino; Luís Monteiro Rodrigues; Patrícia Rijo
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

2.  Anticancer Properties of Plectranthus ornatus-Derived Phytochemicals Inducing Apoptosis via Mitochondrial Pathway.

Authors:  Przemysław Sitarek; Ewelina Synowiec; Tomasz Kowalczyk; Gabrielle Bangay; Tomasz Śliwiński; Laurent Picot; Salvatore Princiotto; Patricia Rijo
Journal:  Int J Mol Sci       Date:  2022-10-01       Impact factor: 6.208

Review 3.  The Botanical, Chemical and Ethnobotanical Diversity of Southern African Lamiaceae.

Authors:  Ryan D Rattray; Ben-Erik Van Wyk
Journal:  Molecules       Date:  2021-06-18       Impact factor: 4.411

4.  Study of the Interference between Plectranthus Species Essential Oils from Brazil and Aminoglycosides.

Authors:  Fabíola Fernandes Galvão Rodrigues; José Galberto Martins Costa; Fábio Fernandes Galvao Rodrigues; Adriana Rolim Campos
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-04       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.